Results 141 to 150 of about 7,748 (181)

Brucella abortus S19 vaccine protects dairy cattle against natural infection with Brucella melitensis

Vaccine, 2016
Brucellosis is a zoonotic disease that can cause severe illness in humans and considerable economic loss in the livestock industry. Although small ruminants are the preferential host for Brucella melitensis, this pathogen has emerged as a cause for Brucella outbreaks in cattle. S19 vaccination is implemented in many countries where B.
Michael, van Straten, Svetlana, Bardenstein, Gaby, Keningswald, Menachem, Banai   +3 more
openaire   +2 more sources

Brucella melitensis Rev. 1 and Brucella abortus 45/20 Vaccines in Goats: Immunity

American Journal of Veterinary Research, 1972
SUMMARY The living attenuated Brucella melitensis Rev. 1 vaccine in reduced dose and the nonliving Brucella abortus 45/20 adjuvant vaccine were examined for suitability in protecting possibly pregnant, adult goats against B. melitensis infection. The immunizing ability of the 2 vaccines was compared with that of the normal dose of Rev.
G G, Alton, L M, Jones, C, García-Carrillo, A, Trenchi   +3 more
openaire   +2 more sources

Rev. 1 Brucella melitensis vaccine

Journal of Comparative Pathology, 1967
G.G. Alton, S.S. Elberg, Dorothy Crouch
openaire   +2 more sources

Protection of Rams Against Brucella ovis Infection by Brucella melitensis Rev. 1 Vaccine

Zentralblatt für Veterinärmedizin Reihe B, 2010
Summary The living attenuated Brucella melitensis Rev. 1 vaccine was evaluated for its capacity to protect rams against severe challenge with virulent B. ovis. Twenty-five rams were vaccinated at 5 months of age and 25 rams were kept as controls.
openaire   +2 more sources

Brucella antibodies and oral cholera vaccination

The Lancet, 1995
R E, Begue, A, Guillen, R, Meza
openaire   +2 more sources

Brucella ovis vaccination of rams

New Zealand Veterinary Journal, 1975
T.D. Quinlivan, G.V. Wallace
openaire   +1 more source

Emerging concepts in the science of vaccine adjuvants

Nature Reviews Drug Discovery, 2021
Bali Pulendran, Prabhu S Arunachalam
exaly  

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Lancet, The, 2021
Merryn Voysey, Shabir A Madhi, Pedro M Folegatti   +2 more
exaly  

Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation

Ca-A Cancer Journal for Clinicians, 2020
Robert A Smith
exaly  

S.19 Brucella abortus vaccine

Veterinary Record, 1968
openaire   +2 more sources